The Multi-Cloud Question: Ambition, Reality and the Occasional Migraine

The Multi-Cloud Question: Ambition, Reality and the Occasional Migraine

At some point, every CTO finds themselves staring into the middle distance wondering whether the organisation should “go multi-cloud.” It usually happens after a pricing change, a vendor webinar, or a board member who read something on Forbes.

The truthful answer — the one that rarely appears in conference slides — is that multi-cloud can be brilliant, necessary, expensive, maddening, strategically wise or operationally ruinous. Sometimes all at once.

Let’s unpack what actually matters for biotech and life sciences teams.

Why Organisations Are Tempted by Multi-Cloud

One of the biggest drivers is the fear of lock-in. Having options feels safe. Being able to negotiate with cloud providers feels even safer. Multi-cloud gives the impression of independence, even if no one in the building really wants to run two sets of IAM policies before breakfast.

Then there’s the lure of best-of-breed services. Each provider has a personality. AWS is the engineer’s playground with every service imaginable. GCP has extraordinary AI and analytics capabilities. Azure makes enterprise integration feel almost civilised. It’s only natural to want a slice of each.

Some teams also need broader geographic coverage, and occasionally multi-cloud is the only way to meet data residency requirements or give global teams low-latency access to research platforms.

And in the world of acquisitions, multi-cloud often arrives uninvited. When you acquire a company that has lived its entire life in Azure or GCP, you’re not going to rewrite everything on day one.

The Uncomfortable Truth: Multi-Cloud Comes With a Bill

And not just the one from the cloud providers.

The complexity multiplies. Every cloud speaks a slightly different dialect. Services behave differently. Identity and access management becomes a puzzle with duplicate pieces. Compliance frameworks diverge. Monitoring stacks multiply. Network architectures grow teeth.

Your people need to understand more platforms, which means more training, higher salaries and a hiring pool that shrinks dramatically. And if you attempt cross-cloud communication, brace yourself for egress fees and data-synchronisation headaches that never make it into the marketing brochures.

Security becomes its own adventure. Ensuring consistent policies across two or three providers requires discipline worthy of a monastery.

When Multi-Cloud Actually Makes Sense

Despite the challenges, there are situations where multi-cloud isn’t just reasonable — it’s the right decision.

If a particular workload absolutely needs the strengths of another provider — for example, pairing GCP’s AI capabilities with AWS’s genomics ecosystem — multi-cloud may be the only practical route.

Some regulatory requirements push you into providers with specific regional availability. In these cases, avoiding multi-cloud simply isn’t an option.

If your organisation is critical enough that you need true platform-level resilience, spreading workload risk can be justified. And if M&A has already landed you in multiple clouds, well… here you are, whether you wanted it or not.

Hybrid cloud scenarios also blur the line — especially when maintaining on-premises infrastructure alongside cloud workloads.

When You’re Better Off Staying Single-Cloud

For early-stage companies or teams with fewer than twenty engineers, multi-cloud is usually a distraction disguised as strategy. Homogeneous workloads don’t gain much from splitting across providers, and few organisations genuinely exhaust the capabilities of a single cloud.

At this stage, simplicity is a competitive advantage. Every hour spent taming multi-cloud plumbing is an hour not spent advancing research or product development.

The Sensible Middle Ground

Rather than fully committing to multi-cloud, many teams adopt a cloud-agnostic design philosophy. Build with containers. Use Kubernetes. Prefer open standards over proprietary services. Architect for portability without actually running everything twice.

This gives you optionality without the operational pain.

Our View After Years in the Trenches

Most biotech and life sciences organisations should begin with one cloud — typically AWS or GCP — and go deep. Build strong foundations. Stay portable where it matters. Expand into a second provider only when the business case is clear, measurable and aligned with real workload needs.

When the time comes, there are mature tools to simplify the journey. Aviatrix for multi-cloud networking. Orca for security. Modern CI/CD pipelines that can target multiple environments. But these tools make sense once the strategy is settled, not as a justification to create a strategy.

The Bottom Line

Multi-cloud is a tool, not a badge of honour. For many organisations, the complexity outweighs the benefits. For others, it’s an enabler of resilience, performance or regulatory alignment.

The key is to choose intentionally — not reactively, and definitely not because a slide at a conference made it look glamorous.

If you’re weighing up your cloud strategy or wrestling with the implications of going multi-cloud, we’re always happy to help you map out what makes sense for your organisation.